Literature DB >> 15946431

Effects of intragastric balloon on gastric emptying and plasma ghrelin levels in non-morbid obese patients.

François Mion1, Bertrand Napoléon, Sabine Roman, Etienne Malvoisin, Frédérique Trepo, Bertrand Pujol, Christine Lefort, Roger-Michel Bory.   

Abstract

BACKGROUND: Intragastric balloons have been proposed to induce weight loss in obese subjects. The consequences of the balloon on gastric physiology remain poorly studied. We studied the influence of an intragastric balloon on gastric emptying and ghrelin secretion in non-morbid obese patients. PATIENTS AND METHODS: 17 patients were included in the study, with mean BMI of 34.4 (range 30.1-40.0). The balloon was inserted under general anaesthesia and endoscopic control, inflated with 600 ml saline, and removed 6 months later. Body weight and gastric emptying (13C-octanoic acid breath test) were monitored while the balloon was in place and 1 month after removal. Ghrelin levels were measured just before balloon insertion and removal.
RESULTS: Mean weight loss was 8.7 kg (range 0-21). Gastric emptying rates were significantly decreased with the balloon in place, and returned to pre-implantation values after balloon removal. Plasma ghrelin levels were significantly decreased (95% CI: -3.8 to -20.7 ng/ml), despite concomitant weight loss. Weight reduction was not correlated to the effect of the balloon on gastric emptying, but was significantly correlated to the ghrelin variations (r=0.668, 95% CI: 0.212-0.885).
CONCLUSIONS: Gastric emptying rates and plasma ghrelin levels are decreased in the presence of intragastric balloon. Weight loss induced by the intragastric balloon is related to ghrelin variations, but not to gastric emptying. Ghrelin inhibition may explain part of the effect of the balloon on satiety.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15946431     DOI: 10.1381/0960892053723411

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  44 in total

Review 1.  Gastrointestinal traits: individualizing therapy for obesity with drugs and devices.

Authors:  Michael Camilleri; Andres Acosta
Journal:  Gastrointest Endosc       Date:  2015-08-10       Impact factor: 9.427

2.  Morbidly obese are ghrelin and leptin hyporesponders with lesser intragastric balloon treatment efficiency : ghrelin and leptin changes in relation to obesity treatment.

Authors:  Marko Nikolic; Marko Boban; Neven Ljubicic; Vladimir Supanc; Gorana Mirosevic; Borka Pezo Nikolic; Ruzica Krpan; Ljubica Posavec; Vanja Zjacic-Rotkvic; Miroslav Bekavac-Beslin; Petar Gacina
Journal:  Obes Surg       Date:  2011-10       Impact factor: 4.129

Review 3.  Evidence-based review of the Bioenterics intragastric balloon for weight loss.

Authors:  Jean-Marc Dumonceau
Journal:  Obes Surg       Date:  2008-06-21       Impact factor: 4.129

Review 4.  Current status of intragastric balloon for obesity treatment.

Authors:  Seung Han Kim; Hoon Jai Chun; Hyuk Soon Choi; Eun Sun Kim; Bora Keum; Yoon Tae Jeen
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

5.  Impact of Intragastric Balloon Before Laparoscopic Gastric Bypass on Patients with Super Obesity: a Randomized Multicenter Study.

Authors:  B Coffin; V Maunoury; F Pattou; X Hébuterne; S Schneider; M Coupaye; S Ledoux; F Iglicki; F Mion; M Robert; E Disse; J Escourrou; G Tuyeras; Y Le Roux; C Arvieux; P Pouderoux; N Huten; T Alfaiate; D Hajage; S Msika
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

6.  Initial Approach to Childhood Obesity in Spain. A Multisociety Expert Panel Assessment.

Authors:  Ramon Vilallonga; José Manuel Moreno Villares; Diego Yeste Fernández; Raquel Sánchez Santos; Felipe Casanueva Freijo; Francisco Santolaya Ochando; Nuria Leal Hernando; Albert Lecube Torelló; Luis Antonio Castaño González; Albert Feliu; Gontrand Lopez-Nava; Dolores Frutos; Felipe de la Cruz Vigo; Antonio J Torres Garcia; Juan Carlos Ruiz de Adana
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

7.  Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicenter study.

Authors:  François Mion; Rodica Gincul; Sabine Roman; Sylvain Beorchia; Frank Hedelius; Nicolas Claudel; Roger-Michel Bory; Etienne Malvoisin; Frédérique Trepo; Bertrand Napoleon
Journal:  Obes Surg       Date:  2007-06       Impact factor: 4.129

8.  Fasting and meal-induced CCK and PP secretion following intragastric balloon treatment for obesity.

Authors:  Elisabeth M H Mathus-Vliegen; Gerrit H de Groot
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

Review 9.  Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis.

Authors:  Iñaki Imaz; Carmen Martínez-Cervell; Elvira Elena García-Alvarez; Juan Manuel Sendra-Gutiérrez; Jesús González-Enríquez
Journal:  Obes Surg       Date:  2008-05-06       Impact factor: 4.129

10.  Safety of the Ullorex oral intragastric balloon for the treatment of obesity.

Authors:  Corby K Martin; Drake E Bellanger; Kristina K Rau; Sandra Coulon; Frank L Greenway
Journal:  J Diabetes Sci Technol       Date:  2007-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.